Blaze Bioscience, Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 9, 2027The maintenance fee for Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereof (US 11,866,466) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 4 of 4
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,048,750 | Tissue-homing peptide conjugates and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,559,580 | Tissue-homing peptide conjugates and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,048,732 | Methods of treating breast cancer In force · From the USPTO record | In force | From the USPTO record | |
| US 11,866,466 | Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereof In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 4: 2 patents in force now held by others · 2 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 6 abandoned · 11 no status recorded
Showing 1 to 10 of 19, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/618,998 | Mar 27, 2024 | No status recorded | |
| 18/518,088 | Nov 22, 2023 | No status recorded | |
| 18/177,642 | Mar 2, 2023 | Abandoned | |
| 18/160,954 | Jan 27, 2023 | No status recorded | |
| 18/683,490 | Transferrin Receptor Targeting Peptide Oligonucleotide Complexes and Methods of Use Thereof | Aug 16, 2022 | Pending |
| 18/037,926 | PD-L1 Binding Peptides and Peptide Complexes and Methods of Use Thereof | Nov 29, 2021 | Abandoned |
| 18/037,923 | Compositions and Methods for Selective Depletion of Target Molecules | Nov 29, 2021 | Pending |
| 18/012,621 | Systems and Methods for Simultaneous Near-Infrared Light and Visible Light Imaging | Jun 25, 2021 | Abandoned |
| 17/230,353 | Apr 14, 2021 | No status recorded | |
| 17/764,132 | Oct 1, 2020 | No status recorded |
10 of 19 applications shown.
Pro members see all 19 published applications.